Provider review

LumiMeds Review: It Fixed the Sentence FDA Wrote To It About

Name: LumiMeds
Brand: LumiMeds
Price: 89 USD
Availability: InStock

FDA cited LumiMeds in 2025 for copy that gave a drug class an approval date and told readers its compounded products had “the same active ingredient as the brand name medications”. The copy live today says “Compounded medications are not FDA-approved”, without being asked. The price is $89 a month, and the letter is still open.

By Marla Whitfield, Pricing EditorAugust 2026

Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.

The money verdict

Cheap, plainly priced, and — unusually — a company whose disclosure now contradicts the copy FDA wrote to it about, in the right direction.

Worth it if

You want a low monthly price with no prepay term attached
You want a company that states compounded drugs are not FDA-approved in its own words
You want NAD+ from the same provider as weight loss

Look elsewhere if

You want a renewal rate or plan term published before you buy
You want the compounding pharmacy named
An open FDA warning letter would stop you buying, even one whose copy has been corrected

Cheapest — Semaglutide

$89/mo

States served

No exclusions disclosed

Billing cycle

Monthly (12×/yr)

At a glance

$89/mo

Advertised

the first-cycle rate

$89/mo

Walk-away

vs. advertised

$1,068

Year at this price

$89 × 12

The same Semaglutide price, three ways

The short bar is the number LumiMeds leads with. It lasts one cycle.

Advertised

first cycle only

$89

Walk-away

every cycle after

$89

Ready to check LumiMeds’s current price?

Verified August 2026. Prices may change.

Best for: You want a low monthly price with no prepay term attached Skip it if: You want a renewal rate or plan term published before you buy

Visit LumiMeds

Pricing, per compound

Everything LumiMeds sells, cheapest year first. “Advertised” is the price it leads with; “Walk-away” is what you pay if you stop after one cycle.

Provider	Advertised	Walk-away	Year at this price
Semaglutide — compounded injection “As low as $89/mo”, with no term, prepay or renewal published — $1,068 a year on the only figure given. The $40 beside it is a referral credit. August 2026	$89.00/mo	$89.00/mo	$1,068.00 $89.00 × 12 months
NAD+ — compounded injection “Start NAD+ injectables for as low as $119/mo”, sold alongside the weight-loss range rather than as a separate program. $1,428 a year. August 2026	$119.00/mo	$119.00/mo	$1,428.00 $119.00 × 12 months

The year at this dose — 12 payments, or 13 where a seller bills every four weeks. Several charge more as you move to a higher dose; where they publish that, the row says so.

Every figure above was read on lumimeds.com, one product at a time. Check the current price before you buy.

See LumiMeds’s prices

How this compares

On our compounded semaglutide board, LumiMeds is $89 and the cheapest we have priced is Embody — weekly injection at $79.
See every compounded semaglutide price we have checked →

Pros and cons

Pros

The copy FDA cited has been corrected.
$89 a month is at the cheap end of the compounded semaglutide market, with no prepay term attached to reach it.
It states that treatments are prescribed by licensed providers through state-licensed compounding pharmacies — the correct licensing authority, which several competitors get wrong.
It says outright that payment does not guarantee a prescription, which is honest about a step most sites gloss.
NAD+ is priced openly rather than requiring a consultation to discover.

Cons

No renewal rate, plan term or membership is published, so “as low as” is the only pricing information available.
No compounding pharmacy is named, so the state-licensed claim cannot be checked against a licensee.
No certificate of analysis or testing result is published.
An open FDA warning letter (716510, September 2025) cited copy assigning FDA approval dates to a drug class and describing compounded products as having the same active ingredient as brand-name medications.
A $40 referral credit appears beside the price, which is not a discount a buyer can rely on.

How we verified this

What we checked

Every price read off lumimeds.com — 2 products, checked one at a time
The billing cycle taken from the company's own terms, not assumed from the price
States, inclusions and cancellation terms read on the company's own pages
Screened against the FDA's live warning-letter index

What to double-check before you buy

Prices may change. Confirm before you buy.

Key terms

Show definitions

Walk-away price: What one cycle costs at the ongoing rate with no commitment — what you actually pay if you stop after month one.
Year at this price: The walk-away price multiplied by however many times a year it's actually billed. ⚠ It's the year at THIS dose — several sellers charge more as you move up, and most don't publish the ladder.
Compounded: Made to order by a pharmacy from raw ingredients, rather than dispensed as an FDA-approved, mass-manufactured product.

Bottom line

$89 a month — $1,068 a year — with no term attached and no renewal rate published, so confirm what happens at month two before you start. Worth noting what most reviews would not: the sentence FDA objected to is gone, replaced by one saying compounded drugs are not FDA-approved.

Visit LumiMeds

FDA warning letter

The FDA sent LumiMeds a warning letter dated September 2025, concerning marketing/labeling.

FDA cited copy that assigns approval dates to a drug class rather than to a product: "GLP-1 Injections contain GLP-1 ... This is the same active ingredient used in brand name GLP-1 weight-loss medications. GLP-1 was FDA-approved in 2017 . . . . It was FDA-approved in 2021 for weight loss." The agency also cited "Doctors frequently recommend Compounded Tirzepatide or Compounded Semaglutide, both of which are GLP-1 agonists with the same active ingredient as the brand name medications," saying such claims imply the compounded products are the same as an FDA-approved product when they are not. ⚠ The copy live on 2026-08-14 states the opposite — "Compounded medications are not FDA-approved. Results may vary." — and none of the cited sentences remains on the site. The letter itself is still open.

FDA warning letters are public regulatory communications. On their own, they are not a finding of illegal activity. Read the letter on fda.gov →

Frequently asked questions

What does LumiMeds cost?

Weight loss is advertised “as low as $89/mo” and NAD+ “as low as $119/mo”. No plan term, prepay requirement, membership or renewal rate is published alongside either, so $1,068 a year is arithmetic on the figure LumiMeds gives rather than a price it quotes.

Does LumiMeds have an FDA warning letter?

Yes — letter 716510, issued 9 September 2025 and still open. It cited copy that gave FDA approval dates to a drug class rather than a product, and described compounded tirzepatide and semaglutide as having the same active ingredient as brand-name medications. The site no longer says any of that; its current disclaimer states that compounded medications are not FDA-approved.

Are its compounded drugs FDA-approved?

No, and LumiMeds now says so itself. Compounded preparations are made to a prescription by a state-licensed pharmacy and are not reviewed or approved by FDA. That is the distinction the company's warning letter turned on.

Sources

Every price above was checked against LumiMeds’s own pricing page — never a third-party aggregator:

Show every source link

LumiMeds — official site
Where we read every figure on this page
Semaglutide pricing
NAD+ pricing
FDA warning letter
September 2025

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.